Abstract
We compared posttransplant outcomes following double-lung transplantation (DLTx) and heart–lung transplantation (HLTx), based on a search of PubMed, Cochrane Library, and Embase, from inception to March 8, 2022, for studies that report outcomes of these procedures. We then performed a meta-analysis of baseline characteristics and posttransplant outcomes. Subgroup analyses were implemented according to indication, publication year, and center. This study was registered on PROSPERO (number CRD42020223493). Ten studies were included in this meta-analysis, involving 1230 DLTx patients and 1022 HLTx patients. The DLTx group was characterized by older donors (P = 0.04) and a longer allograft ischemia time (P < 0.001) than the HLTx group. The two groups had comparable 1-year, 3-year, 5-year, 10-year survival rates (all P > 0.05), with similar results identified in subgroup analyses. We found no significant differences in 1-year, 5-year, and 10-year chronic lung allograft dysfunction (CLAD)-free survival, length of intensive care unit stay and hospital stay, length of postoperative ventilation, in-hospital mortality, or surgical complications between the groups (all P > 0.05). Thus, DLTx provides similar posttransplant survival to HLTx for end-stage cardiopulmonary disease. These two procedures have a comparable risk of CLAD and other posttransplant outcomes.
Similar content being viewed by others
References
Reitz BA, Wallwork JL, Hunt SA, Pennock JL, Billingham ME, Oyer PE, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med. 1982;306(10):557–64.
Kramer MR, Valantine HA, Marshall SE, Starnes VA, Theodore J. Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. Am J Cardiol. 1994;73(7):494–500.
Moulton MJ, Creswell LL, Ungacta FF, Downing SW, Szabó BA, Pasque MK. Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation. 1996;94(9 Suppl): Ii312–9.
Chambers DC, Cherikh WS, Harhay MO, Hayes D Jr, Hsich E, Khush KK, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transp. 2019;38(10):1042–55.
López-Meseguer M, Quezada CA, Ramon MA, Lázaro M, Dos L, Lara A, et al. Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One. 2017;12(11): e0187811.
Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Levvey BJ, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant. J Heart Lung Transp. 2016;35(10):1170–84.
Chambers DC, Cherikh WS, Goldfarb SB, Hayes D Jr, Kucheryavaya AY, Toll AE, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation. J Heart Lung Transp. 2018;37(10):1169–83.
Brouckaert J, Verleden SE, Verbelen T, Coosemans W, Decaluwé H, De Leyn P, et al. Double-lung versus heart-lung transplantation for precapillary pulmonary arterial hypertension: a 24-year single-center retrospective study. Transpl Int. 2019;32(7):717–29.
Hill C, Maxwell B, Boulate D, Haddad F, Ha R, Afshar K, et al. Heart–lung vs. double-lung transplantation for idiopathic pulmonary arterial hypertension. Clin Transp. 2015;29(12): 1067–75.
Sertic F, Han J, Diagne D, Richards T, Chavez L, Berg A, et al. Not all septal defects are equal: outcomes of bilateral lung transplant with cardiac defect repair vs combined heart–lung transplant in patients with eisenmenger syndrome in the United States. Chest. 2020;158(5):2097–106.
Vricella LA, Karamichalis JM, Ahmad S, Robbins RC, Whyte RI, et al. Reitz, lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the stanford experience. Ann Thorac Surg. 2002;74(1): 13–7 (discussion 17–8)
Swaminathan AC, Todd JL, Palmer SM. Advances in human lung transplantation. Annu Rev Med. 2021;27(72):135–49.
Narula J, Bennett LE, DiSalvo T, Hosenpud JD, Semigran MJ, Dec GW. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation. 1997;63(6):861–7.
Ganesh JS, Rogers CA, Bonser RS, Banner NR. Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. Eur Respir J. 2005;25(6):964–9.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350: g7647.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
Tian D, Wang Y, Shiiya H, Sun CB, Uemura Y, Sato M, et al. Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2020;159(2):720-730.e6.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
Egger M, Davey Smith G, Schneider M, Minder C, Schneider, C. Minder. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109): 629–34
de Perrot M, Granton JT, McRae K, Pierre AF, Singer LG, Waddell TK, et al. Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience. J Thorac Cardiovasc Surg. 2012;143(4):910–8.
Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Ann Thorac Surg, 2006;81(1): 286–91 (discussion 291)
Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Trans. 2005;24(11):1834–43.
Fadel E, Mercier O, Mussot S, Leroy-Ladurie F, Cerrina J, Chapelier A, et al. Long-term outcome of double-lung and heart-lung transplantation for pulmonary hypertension: a comparative retrospective study of 219 patients. Eur J Cardiothorac Surg. 2010;38(3):277–84.
Wahlers T, Haverich A, Schäfers HJ, Hirt SW, Fieguth HG, Jurmann M, et al. Chronic rejection following lung transplantation. Incidence, time pattern and consequences. Eur J Cardiothorac Surg. 1993;7(6): 319–23 (discussion 324)
Ueno T, Smith JA, Snell GI, Williams TJ, Kotsimbos TC, Rabinov M, et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger’s syndrome. Ann Thorac Surg. 2000;69(2):381–7.
Lordan JL, Corris PA. Pulmonary arterial hypertension and lung transplantation. Expert Rev Respir Med. 2011;5(3):441–54.
Habedank D, Ewert R, Hummel M, Dandel M, Habedank F, Knosalla C, et al. The effects of bilateral lung transplantation on ventilatory efficiency, oxygen uptake and the right heart: a 2-year follow-up. Clin Transpl. 2011;25(1):E38-45.
Franke U, Wiebe K, Harringer W, Franke T, Wittwer T, Wahlers T, et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg. 2000;18(4):447–52.
Shigemura N, Sareyyupoglu B, Bhama J, Bonde P, Thacker J, Bermudez C, et al. Combining tricuspid valve repair with double lung transplantation in patients with severe pulmonary hypertension, tricuspid regurgitation, and right ventricular dysfunction. Chest. 2011;140(4):1033–9.
McCurry KR. Brief overview of lung, heart, and heart-lung transplantation. Crit Care Clin. 2019;35(1):1–9.
Bando K, Armitage JM, Paradis IL, Keenan RJ, Hardesty RL, Konishi H, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg. 1994;108(6):1056–65.
Olland A, Falcoz PE, Canuet M, Massard G. Should we perform bilateral-lung or heart–lung transplantation for patients with pulmonary hypertension? Interact Cardiovasc Thorac Surg. 2013;17(1):166–70.
Pielsticker EJ, Martinez FJ, Rubenfire M. Lung and heart-lung transplant practice patterns in pulmonary hypertension centers. J Heart Lung Transp. 2001;20(12):1297–304.
Goerler H, Simon A, Gohrbandt B, Hagl C, Oppelt P, Weidemann J, et al. Heart-lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience. Eur J Cardiothorac Surg. 2007;32(6):926–31.
Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transp. 2002;21(7):731–7.
Kearney K, Lau EM, Darley D, Romfh A, Bart N, Kotlyar E, et al. Waitlist and post-transplant outcomes for eisenmenger syndrome: a comparison of transplant strategies. J Heart Lung Transp. 2021;40(8):841–9.
Barlow CW, Robbins RC, Moon MR, Akindipe O, Theodore J, Reitz BA. Heart-lung versus double-lung transplantation for suppurative lung disease. J Thorac Cardiovasc Surg. 2000;119(3):466–76.
Toyoda Y, Thacker J, Santos R, Nguyen D, Bhama J, Bermudez C, et al. Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg. 2008;86(4):1116–22.
Pinderski LJ, Kirklin JK, McGiffin D, Brown R, Naftel DC, Young KR Jr, et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transp. 2005;24(11):1828–33.
Keenan RJ, Bruzzone P, Paradis IL, Yousem SA, Dauber JH, Stuart RS, et al. Similarity of pulmonary rejection patterns among heart-lung and double-lung transplant recipients. Transplantation. 1991;51(1):176–80.
Takahashi T, Terada Y, Pasque MK, Itoh A, Nava RG, Puri V, et al. Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor. Clin Transp. 2020;34(1): e13768.
Yang YL, Xiang ZJ, Yang JH, Wang WJ, Xu ZC, Xiang RL. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J. 2020;41(46):4415–22.
Acknowledgements
We thank all authors of the articles that were included in this systematic review and meta-analysis, especially Dr. Dirk Van Raemdonck and colleagues (Department of Thoracic Surgery, University Hospitals Leuven) who provided unpublished data for this study after we contacted them by email. We appreciate the American Journal Experts (https://secure.aje.com/cn/researcher/) for editing the English text of a draft of this manuscript.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
We have no conflicts of interest to declare in relation to this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yan, HJ., Zheng, XY., Huang, H. et al. Double-lung versus heart–lung transplantation for end-stage cardiopulmonary disease: a systematic review and meta-analysis. Surg Today 53, 1001–1012 (2023). https://doi.org/10.1007/s00595-022-02579-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-022-02579-4